paricord (paricalcitol injection 5 mcgml)
accord healthcare sdn.bhd. - paricalcitol -
paricalcitol normon 5 mikrogramm/ml injektionslösung
paricalcitol sun 5 mikrogramm/ml injektionslösung
paricalcitol sun 2 mikrogramm/ml injektionslösung
curatoderm 4micrograms/g lotion
almirall ltd - tacalcitol monohydrate - cutaneous emulsion - 4microgram/1gram
curatoderm 4micrograms/g ointment
almirall ltd - tacalcitol monohydrate - cutaneous ointment - 4microgram/1gram
zemplar capsules 1 mcg
abbvie sdn bhd - paricalcitol -
paricalcitol normon 2 mikrogramm/ml injektionslösung
parizem
douglas pharmaceuticals limited - paricalcitol 1ug - liquid filled capsule - 1 mcg - active: paricalcitol 1ug excipient: butylated hydroxytoluene ethanol gelatin glycerol medium-chain triglycerides purified water titanium dioxide - indicated in adult and paediatric patients 10 to 16 years of age for the prevention and treatment of secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4. also indicated in adult patients for the prevention and treatment of secondary hyperparathyroidism associated with chronic kidney disease stage 5 in patients who are on haemodialysis or peritoneal dialysis.
parizem
douglas pharmaceuticals limited - paricalcitol 2ug - liquid filled capsule - 2 mcg - active: paricalcitol 2ug excipient: butylated hydroxytoluene ethanol gelatin glycerol iron oxide red medium-chain triglycerides purified water titanium dioxide - indicated in adult and paediatric patients 10 to 16 years of age for the prevention and treatment of secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4. also indicated in adult patients for the prevention and treatment of secondary hyperparathyroidism associated with chronic kidney disease stage 5 in patients who are on haemodialysis or peritoneal dialysis.